Tag Archives: MOTS

Motus Gi Holdings (MOTS) Received its Third Buy in a Row

After Colliers Securities and Oppenheimer gave Motus Gi Holdings (NASDAQ: MOTS) a Buy rating last month, the company received another Buy, this time from H.C. Wainwright. Analyst Yi Chen reiterated a Buy rating on Motus Gi Holdings today and set

Motus Gi Holdings (MOTS) Receives a Buy from Oppenheimer

In a report released yesterday, Steven Lichtman from Oppenheimer maintained a Buy rating on Motus Gi Holdings (MOTS – Research Report), with a price target of $2.50. The company’s shares closed last Tuesday at $1.19. According to TipRanks.com, Lichtman is

Analysts Are Bullish on These Healthcare Stocks: Motus Gi Holdings (MOTS), Cytokinetics (CYTK)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Motus Gi Holdings (MOTS – Research Report), Cytokinetics (CYTK – Research Report) and Flowr (FLWPF – Research Report) with bullish sentiments. Motus

Analysts Conflicted on These Healthcare Names: Motus Gi Holdings Inc (NASDAQ: MOTS) and Irhythm Technologies (NASDAQ: IRTC)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Motus Gi Holdings Inc (MOTS – Research Report) and Irhythm Technologies (IRTC – Research Report). Motus Gi Holdings Inc (MOTS) In a report released today,

Piper Jaffray Remains a Buy on Motus Gi Holdings Inc (MOTS)

Piper Jaffray analyst Matthew O’Brien reiterated a Buy rating on Motus Gi Holdings Inc (NASDAQ: MOTS) on August 14 and set a price target of $8. The company’s shares opened today at $5.35. According to TipRanks.com, O’Brien is a top

Oppenheimer Keeps a Buy Rating on Motus Gi Holdings Inc (MOTS)

Oppenheimer analyst Steven Lichtman maintained a Buy rating on Motus Gi Holdings Inc (NASDAQ: MOTS) today and set a price target of $10. The company’s shares closed yesterday at $5.41. Lichtman commented: “We caught up with MOTS management following the